Biogen
BIIB
BIIB
884 hedge funds and large institutions have $72.3B invested in Biogen in 2014 Q4 according to their latest regulatory filings, with 130 funds opening new positions, 343 increasing their positions, 279 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $71B → $72.3B (+$1.3B)
28% less call options, than puts
Call options by funds: $975M | Put options by funds: $1.36B
Holders
884
Holding in Top 10
52
Calls
$975M
Puts
$1.36B
Top Buyers
| 1 | +$342M | |
| 2 | +$316M | |
| 3 | +$267M | |
| 4 |
Goldman Sachs
New York
|
+$207M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$205M |
Top Sellers
| 1 | -$1.75B | |
| 2 | -$253M | |
| 3 | -$234M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$209M |
| 5 |
CCI
Columbus Circle Investors
|
-$185M |